glucaric acid has been researched along with losartan potassium in 82 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (20.73) | 18.2507 |
| 2000's | 49 (59.76) | 29.6817 |
| 2010's | 16 (19.51) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, M; Frank, N; Iaina, A; Kaplan, E; Levi, BA; Peer, G; Silverberg, DS; Steinbruch, S | 1 |
| Mercuriali, F | 2 |
| Tryba, M | 1 |
| Commerford, A; Haworth, C; Meyer, JH; Meyer, MP | 1 |
| Blum, M; Iaina, A; Kaplan, E; Peer, G; Silverberg, DS | 1 |
| Hörl, WH; Sunder-Plassmann, G | 2 |
| Hörl, WH; Spitzauer, S; Sunder-Plassmann, G | 1 |
| Cazzola, M | 1 |
| Akcicek, F; Atabay, G; Basci, A; Celik, A; Cirit, M; Ok, E; Ozkahya, M; Toz, H; Unsal, A | 1 |
| Abdalla, AH; al-Hawas, F; al-Khader, AA; al-Sulaiman, MH; Mousa, DH; Popovich, W | 1 |
| Andrade, S; Colaço, S; Oliveira, C; Ponce, P; Santos, JP; Silva, J; Ventura, H | 1 |
| Atherton, DJ; Cox, I; Hann, I | 1 |
| Dejaco, C; Fueger, GF; Gangl, A; Gasche, C; Lochs, H; Reinisch, W; Tillinger, W; Waldhoer, T | 1 |
| Claris, O; Picaud, JC; Putet, G; Salle, BL | 1 |
| Breymann, C; Huch, A; Huch, R; Hüttner, C; Krafft, A | 1 |
| Bailie, GR; Johnson, CA; Mason, NA | 1 |
| Descombes, E; Fellay, G | 1 |
| Adhikarla, R; Cavallo, G; Charytan, C; Gagnon, S; Levin, N; Spinowitz, BS; Van Wyck, DB | 1 |
| Grönhagen-Riska, C; Parkkinen, J; Peltonen, S; Rosenlöf, K; von Bonsdorff, L | 1 |
| Chang, HY; Chen, KS; Kao, HH; Lee, CC; Tsai, CJ | 1 |
| Hayde, M; Hayn, M; Herkner, K; Lombard, KA; Lubec, G; Pollak, A; Weninger, M; Widness, JA | 1 |
| Al-Saloum, M; Charytan, C; Gagnon, S; Hafeez, T; Levin, N; Van Wyck, DB | 1 |
| Breymann, C; Huch, A; Huch, R; Visca, E | 1 |
| Agbaria, Z; Baruch, R; Blum, M; Deutsch, V; Iaina, A; Irony, M; Schwartz, D; Silverberg, DS; Steinbruch, S; Yachnin, T | 1 |
| Inglis, H; Newstead, CG; Stoves, J | 1 |
| Bahner, U; Bettger, H; Kosch, M; Matzkies, F; Schaefer, RM; Teschner, M | 1 |
| Feichtenschlager, T; Gasche, C; Male, C; Mayer, A; Mittermaier, C; Petritsch, W; Waldhoer, T | 1 |
| Gottschalk, R; Kaltwasser, JP; Kessler, U; Möller, B; Stucki, G | 1 |
| Baruch, R; Blum, M; Iaina, A; Keren, G; Schwartz, D; Shaked, M; Sheps, D; Silverberg, DS; Steinbruch, S; Tchebiner, J; Wexler, D; Yachnin, T; Zubkov, A | 2 |
| Eran, A; Harmankaya, O | 1 |
| Chuang, CL; Huang, TP; Liu, RS; Tarng, DC; Wei, YH | 1 |
| Albarracín, C; Fanlo, B; Junquera, E; Rodríguez Palomares, JR | 1 |
| Blum, M; Iaina, A; Keren, G; Schwartz, D; Sheps, D; Silverberg, DS; Wexler, D | 1 |
| Bugat, R; Mourey, L; Séronie-Vivien, S; Tohfe, M | 1 |
| Borisov, AV; Borisova, EV; Fesiuk, AF; Lovchinskiĭ, EV; Mordik, AI | 1 |
| Goldenberg, H; Lutzky, B; Schaufler, R; Scheiber-Mojdehkar, B; Sturm, B | 1 |
| Chester, K; McMahon, LP; Walker, RG | 1 |
| Eiam-Ong, S; Praditpornsilpa, K; Tiranathanagul, K; Tosukhowong, P; Tungsanga, K | 1 |
| Macdougall, IC; Roche, A | 1 |
| Collins, AJ; Obrador, GT; Roberts, TL; St Peter, WL | 1 |
| Ghannam, M; Karkouti, K; McCluskey, SA; Quirt, I; Salpeter, MJ; Yau, TM | 1 |
| Anbu, AT; Bradbury, MG; Kemp, T; O'donnell, K; Smith, PA | 1 |
| Karmiris, K; Kouroumalis, EA; Koutroubakis, IE; Makreas, S; Niniraki, M; Xidakis, C | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L | 1 |
| Ambühl, PM; Binet, I; Dickenmann, M; Keusch, G; Lüthi, L; Schiesser, D; Schmidli, M; Tsinalis, D; Wüthrich, RP | 1 |
| Cardona, R; Cuenca, J; García-Erce, JA; Martínez, F; Muñoz, M; Pérez-Serrano, L | 1 |
| Cuenca Espiérrez, J; García-Erce, JA; Gómez Barrera, M; Izuel Rami, M; Rabanaque Hernández, MJ; Villar Fernández, I | 1 |
| Camps, J; Ferré, N; Joven, J; Mackness, B; Mackness, M; Marcas, L; Marsillach, J; Martínez-Vea, A | 1 |
| Huch, R; Krafft, A; Schaefer, RM | 1 |
| Charytan, C; Reed, J; Yee, J | 1 |
| Martinez, A; Thomas, J | 1 |
| Cangiano, JL; Noble, S; Reed, J; Singh, H; Van Wyck, DB | 1 |
| Francis, GS; Kanderian, A | 1 |
| Li, H; Wang, SX | 1 |
| Bailey, G; Cropper, L; Mostafa, S; Pugh-Clarke, K; Tagboto, S; Turner, J | 1 |
| Arnaout, L; Bellamy, L; Chabbouh, T; Ozier, Y; Rosencher, N | 1 |
| Lorch, JA; Pollak, VE; Satwah, S; Shukla, R | 1 |
| Dejaco, C; Gasche, C; Kulnigg, S; Teischinger, L; Waldhör, T | 1 |
| Cuenca, J; García-Erce, JA; Haman-Alcober, S; Herrera, A; Martínez, AA; Muñoz, M | 1 |
| Nguyen, TV | 1 |
| Bencaiova, G; Breymann, C; Krafft, A | 1 |
| Bruguera, J; Cladellas, M; Comín-Colet, J; Rizzo, M; Ruiz, S; Torres, A | 1 |
| Alonso, E; Canser, E; Gilsanz, F; Gredilla, E; Martínez Serrano, B; Pérez-Ferrer, A | 1 |
| Fernández-Gallego, J; Martín, MA; Sujan, S; Vega, E | 1 |
| Breymann, C; Krafft, A | 1 |
| Kim, S; Lee, SC; Lim, H; Yoon, J | 1 |
| Dansaert, A; Kadri, A; Lafuma, A; Leonard, E; Rottembourg, J | 1 |
| Korejo, R; Nasir, A; Yasmin, H | 1 |
| Conner, TA; McQuade, C; Olp, J; Pai, AB | 1 |
| Bosch, MA; Bruguera, J; Cladellas, M; Comín-Colet, J; Farré, N; Gómez, M; Meroño, O; Molera, R; Segovia, A; Vila, J | 1 |
| Bradbury, BD; Brookhart, MA; Freburger, JK; Kshirsagar, AV; Ng, LJ | 1 |
| Basora, M; Ciercoles, E; Colomina, MJ; Mora, L; Salazar, F; Tio, M | 1 |
| Lynn, S; McDaniel, J | 1 |
| Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Seidel, L; Servais, S; Vanstraelen, G; Willems, E | 1 |
| Mekic, M; Musanovic, A; Trnacevic, S | 1 |
| Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Servais, S; Willems, É | 1 |
| Ang, D; Bavry, AA; Beck, A; Efron, P; Rebel, A | 1 |
| Kozlovskaya, LV; Markina, MM; Milovanov, YS; Milovanova, SY; Mukhin, NA | 1 |
| Hamano, H; Hirayama, T; Horinouchi, Y; Ikeda, Y; Ishizawa, K; Izawa-Ishizawa, Y; Kihira, Y; Kishi, S; Miyamoto, L; Nagasawa, H; Oshima, K; Tamaki, T; Tsuchiya, K; Watanabe, H | 1 |
5 review(s) available for glucaric acid and losartan potassium
| Article | Year |
|---|---|
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Safety aspects of parenteral iron in patients with end-stage renal disease.
Topics: Anemia, Iron-Deficiency; Citric Acid; Drug Combinations; Drug Monitoring; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Compounds; Iron Overload; Iron-Dextran Complex; Kidney Failure, Chronic; Sorbitol | 1997 |
[Iron supplementation in preterm infants treated with erythropoietin].
Topics: Adult; Dietary Supplements; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Kidney Failure, Chronic; Recombinant Proteins | 1999 |
Parenteral iron use in the management of anemia in end-stage renal disease patients.
Topics: Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Peritoneal Dialysis; Recombinant Proteins; Renal Dialysis | 2000 |
[Blood conservation approaches in orthopedic surgery].
Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemodilution; Humans; Intraoperative Complications; Orthopedic Procedures; Postoperative Hemorrhage; Preoperative Care; Recombinant Proteins; Sucrose; Time Factors; Tranexamic Acid; Transfusion Reaction | 2008 |
40 trial(s) available for glucaric acid and losartan potassium
| Article | Year |
|---|---|
Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery.
Topics: Administration, Oral; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Prosthesis; Humans; Injections, Intravenous; Premedication; Recombinant Proteins; Safety; Treatment Outcome | 1996 |
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.
Topics: Anemia; Blood Transfusion; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Male; Orthopedics; Premedication; Recombinant Proteins; Reticulocyte Count; Sex Characteristics; Treatment Outcome | 1996 |
A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
Topics: Administration, Oral; Anemia, Neonatal; Blood Cell Count; Blood Transfusion; Erythrocyte Count; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematocrit; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Iron; Lactates; Male; Recombinant Proteins; Reticulocytes | 1996 |
Intravenous ferric saccharate as an iron supplement in dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Combinations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Renal Dialysis | 1996 |
Safety of intravenous injection of iron saccharate in haemodialysis patients.
Topics: Adult; Aged; Drug Tolerance; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Transferrin | 1996 |
The efficiency of fractionated parenteral iron treatment in CAPD patients.
Topics: Adult; Anemia; Drug Administration Schedule; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Organization and Administration; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Sucrose; Transferrin | 1997 |
Iron supplementation in haemodialysis--practical clinical guidelines.
Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Administration Routes; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Deficiencies; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Support; Practice Guidelines as Topic; Prospective Studies; Recombinant Proteins; Renal Dialysis; Sucrose; Transferrin | 1998 |
Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.
Topics: Adult; Anemia, Iron-Deficiency; C-Reactive Protein; Colitis, Ulcerative; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Glucocorticoids; Hemoglobins; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Recombinant Proteins; Reticulocyte Count; Treatment Outcome | 1999 |
Erythropoietic quality of maternal milk.
Topics: Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Infant, Premature; Milk, Human; Recombinant Proteins | 1999 |
Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.
Topics: Anemia, Iron-Deficiency; Blood Pressure; Drug Hypersensitivity; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2000 |
Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration.
Topics: Adult; Aged; Bleomycin; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Staphylococcus epidermidis; Transferrin | 2000 |
Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy.
Topics: Anemia; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Middle Aged; Recombinant Proteins; Renal Dialysis; Uremia | 2000 |
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Topics: Administration, Oral; Ascorbic Acid; Blood Cell Count; Drug Therapy, Combination; Erythrocyte Indices; Erythrocyte Transfusion; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Iron; Malondialdehyde; Prospective Studies; Tyrosine | 2001 |
Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
Topics: Aged; Anemia, Iron-Deficiency; Epoetin Alfa; Erythrocyte Indices; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2001 |
Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.
Topics: Anemia, Iron-Deficiency; Erythrocyte Count; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fetal Growth Retardation; Glucaric Acid; Hematocrit; Humans; Placental Insufficiency; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Recombinant Proteins; Reticulocyte Count; Transferrin; Treatment Outcome; Ultrasonography | 2001 |
The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Sucrose | 2001 |
A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
Topics: Administration, Oral; Aged; Disease Progression; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Gastrointestinal Diseases; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency | 2001 |
A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
Topics: Drug Administration Schedule; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Recombinant Proteins; Renal Dialysis; Sucrose; Time Factors; Transferrin | 2001 |
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
Topics: Anemia, Iron-Deficiency; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Interleukin-6; Logistic Models; Male; Prospective Studies; Receptors, Transferrin; ROC Curve; Sensitivity and Specificity; Transferrin; Treatment Outcome | 2001 |
Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
Topics: Adult; Aged; Anemia; Arthritis, Rheumatoid; Disability Evaluation; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Status; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Quality of Life; Recombinant Proteins; Severity of Illness Index; Treatment Outcome | 2001 |
Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
Topics: Aged; Anemia; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2002 |
Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Renal Insufficiency; Severity of Illness Index; Time Factors | 2003 |
Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients.
Topics: Antioxidants; Cross-Over Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis; Thiobarbituric Acid Reactive Substances | 2004 |
Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections.
Topics: Adult; Aged; Anaphylaxis; Anemia, Hypochromic; Chronic Disease; Cohort Studies; Dysgeusia; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Graft Rejection; Humans; Hypotension; Injections, Intravenous; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies | 2005 |
Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia.
Topics: Analysis of Variance; Anemia; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthopedic Procedures; Postoperative Care; Recombinant Proteins; Time Factors; Treatment Outcome | 2006 |
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients.
Topics: Adolescent; Adult; Aged; Darbepoetin alfa; Dose-Response Relationship, Drug; Drug Administration Schedule; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis; Transferrin; Treatment Outcome | 2006 |
Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery.
Topics: Aged; Anemia; Arthroplasty, Replacement, Knee; Blood Component Transfusion; Blood Loss, Surgical; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Perioperative Care; Postoperative Hemorrhage; Receptors, Transferrin; Recombinant Proteins; Reticulocyte Count; Treatment Outcome | 2006 |
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Topics: Aged; Anemia; Antibodies; Aryldialkylphosphatase; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis; Treatment Outcome | 2007 |
Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.
Topics: Anemia, Iron-Deficiency; Darbepoetin alfa; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Peritoneal Dialysis; Recombinant Proteins | 2006 |
Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Topics: Adult; Aged; Anemia; China; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Treatment Outcome | 2008 |
Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Administration Schedule; Drug Monitoring; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glomerular Filtration Rate; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Severity of Illness Index; Sucrose; Transferrin; Treatment Outcome | 2008 |
Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
Topics: Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Iron; Male; Prognosis; Prospective Studies; Recurrence; Treatment Outcome | 2009 |
Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Blood Loss, Surgical; Blood Transfusion; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid; Fracture Fixation, Internal; Glucaric Acid; Guideline Adherence; Hip Fractures; Hospitals, University; Humans; Male; Postoperative Complications; Premedication; Prospective Studies; Recombinant Proteins; Retrospective Studies; Vitamin B 12 | 2009 |
Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Topics: Adult; Anemia; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Pregnancy; Recombinant Proteins; Treatment Outcome | 2009 |
Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Topics: Anemia; Anemia, Iron-Deficiency; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Interleukin-6; Pregnancy; Pregnancy Complications; Prospective Studies; Recombinant Proteins; Treatment Outcome | 2011 |
Do two intravenous iron sucrose preparations have the same efficacy?
Topics: Anemia, Iron-Deficiency; Cohort Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Prognosis; Renal Dialysis | 2011 |
Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
Topics: Adult; Ascorbic Acid; Cross-Over Studies; Cytokines; Epoetin Alfa; Erythropoietin; F2-Isoprostanes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Middle Aged; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Recombinant Proteins; Systems Biology | 2012 |
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.
Topics: Aged; Anemia; Blood Transfusion; Combined Modality Therapy; Darbepoetin alfa; Drug Therapy, Combination; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lymphoma; Male; Middle Aged; Multiple Myeloma; Postoperative Complications; Quality of Life; Transferrin; Transplantation Conditioning; Transplantation, Autologous | 2013 |
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
Topics: Anemia; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Sucrose; Survival Analysis; Transplantation, Autologous | 2015 |
38 other study(ies) available for glucaric acid and losartan potassium
| Article | Year |
|---|---|
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
Topics: Administration, Oral; Adult; Aged; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors | 1996 |
The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures.
Topics: Aged; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Male; Methods; Middle Aged; Recombinant Proteins; Renal Dialysis; Sensitivity and Specificity; Transferrin | 1997 |
Recombinant human erythropoietin to assist autologous blood donation by patients with anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Donors; Blood Transfusion, Autologous; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Recombinant Proteins | 1997 |
Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin.
Topics: Administration, Oral; Adult; Aged; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Male; Middle Aged; Renal Dialysis; Retreatment; Treatment Outcome | 1997 |
Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa.
Topics: Anemia, Iron-Deficiency; Child; Epidermolysis Bullosa Dystrophica; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Recombinant Proteins; Sucrose | 1999 |
Improved response to erythropoietin therapy with long-term continuous iron supplementation.
Topics: Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis | 2000 |
Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.
Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Humans; Kidney Failure, Chronic; Male; Recombinant Proteins; Stroke Volume; Sucrose | 2001 |
The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.
Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hospitalization; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Oxygen Consumption; Recombinant Proteins; Stroke Volume | 2002 |
Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Topics: Anemia, Iron-Deficiency; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fluorescence; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Recombinant Proteins; Renal Dialysis; Reticulocyte Count; Reticulocytes | 2003 |
[Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
Topics: Aged; Aged, 80 and over; Anemia; Cost-Benefit Analysis; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spain; Sucrose | 2003 |
Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report.
Topics: Anemia; Chronic Disease; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Radiation Injuries; Recombinant Proteins; Reticulocyte Count | 2003 |
[Use of venofer for iron deficiency correction in patients undergoing programmed hemodialysis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Sucrose; Treatment Outcome | 2003 |
Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation.
Topics: Blotting, Western; Cell Line; Citric Acid; Electrophoresis, Polyacrylamide Gel; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fluoresceins; Glucaric Acid; Humans; Iron; Oxidative Stress; Peroxides; Quaternary Ammonium Compounds; Renal Dialysis; Time Factors; Transferrin; Urea | 2004 |
Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis.
Topics: Adult; Aged; Darbepoetin alfa; Enoxaparin; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematologic Agents; Humans; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2004 |
Trends in intravenous iron use among dialysis patients in the United States (1994-2002).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hypochromic; Child; Child, Preschool; Drug Utilization; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Incidence; Infant; Infusions, Intravenous; Kidney Failure, Chronic; Male; Medicare; Middle Aged; Outpatients; Peritoneal Dialysis; Prevalence; Recombinant Proteins; Renal Dialysis; Retrospective Studies; United States | 2005 |
Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin.
Topics: Anemia; Child; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Prospective Studies; Recombinant Proteins | 2005 |
Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study.
Topics: Anemia, Refractory; C-Reactive Protein; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Interleukin-6; Male; Pilot Projects; Receptors, Transferrin; Transferrin; Treatment Outcome | 2006 |
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines | 2006 |
[Budget impact analysis of a blood saving program for urgent traumatological surgery].
Topics: Administration, Oral; Age Factors; Aged, 80 and over; Anemia; Budgets; Confidence Intervals; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Iron; Length of Stay; Male; Recombinant Proteins | 2007 |
[Current recommendations for the treatment of iron deficiency anemia].
Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Therapy, Combination; Epoetin Alfa; Erythrocyte Count; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Recombinant Proteins; Sucrose; Switzerland; Transferrin | 2007 |
The safety of intravenous iron sucrose use in the elderly patient.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Geriatrics; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2007 |
Blood conservation in the critically ill.
Topics: Adult; Aged; Anemia; Baltimore; Blood; Blood Chemical Analysis; Clinical Protocols; Critical Care; Critical Illness; Drug Costs; Drug Monitoring; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pilot Projects; Recombinant Proteins | 2007 |
Anemia and heart failure a new pathway?
Topics: Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Infusions, Intravenous; Natriuretic Peptide, Brain; Peptide Fragments; Treatment Outcome | 2007 |
The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
Topics: Adult; Aged; Anemia; Comorbidity; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Renal Dialysis; Retrospective Studies; Survival Analysis; Transferrin | 2009 |
Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
Topics: Adult; Anemia; Cohort Studies; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Renal Dialysis; Retrospective Studies; Transferrin | 2009 |
A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical ou
Topics: Aged; Aged, 80 and over; Anemia; Chronic Disease; Cohort Studies; Drug Evaluation; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Neurotransmitter Agents; Pilot Projects; Prospective Studies; Recombinant Proteins; Survival Rate; Syndrome; Time Factors; Treatment Outcome | 2009 |
[Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases].
Topics: Adult; Anemia; Anti-Anxiety Agents; Anticoagulants; Cervix Uteri; Combined Modality Therapy; Contraceptives, Oral, Hormonal; Dalteparin; Embolization, Therapeutic; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Immobilization; Jehovah's Witnesses; Menorrhagia; Oxygen Inhalation Therapy; Parenteral Nutrition; Postpartum Hemorrhage; Pregnancy; Recombinant Proteins; Thromboembolism; Treatment Refusal; Young Adult | 2009 |
[Treatment with intravenous iron and ferritin level].
Topics: Anemia; Blood Proteins; Case-Control Studies; Clinical Protocols; Drug Monitoring; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Oxidation-Reduction; Prospective Studies; Renal Dialysis | 2010 |
Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans | 2010 |
Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi.
Topics: Academic Medical Centers; Adult; Anemia, Iron-Deficiency; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Hematinics; Humans; Pakistan; Preoperative Care; Recombinant Proteins; Reticulocyte Count; Time Factors; Treatment Outcome | 2011 |
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement.
Topics: Aged; Anemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hematinics; Hospital Mortality; Humans; Infusions, Intravenous; Male; Postoperative Period; Preoperative Care; Prospective Studies; Recombinant Proteins; Risk Factors; Spain; Sucrose; Survival Rate; Treatment Outcome | 2012 |
Changing patterns of anemia management in US hemodialysis patients.
Topics: Adolescent; Adult; Aged; Anemia; Child; Child, Preschool; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron Compounds; Kidney Failure, Chronic; Male; Middle Aged; Practice Patterns, Physicians'; Renal Dialysis; Time Factors; United States | 2012 |
Optimizing preoperative haemoglobin with intravenous iron.
Topics: Adult; Aged; Aged, 80 and over; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobinometry; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthopedic Procedures; Recombinant Proteins; Young Adult | 2013 |
Managing severe anemia when the patient is a Jehovah's Witness.
Topics: Adult; Anemia, Iron-Deficiency; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Fluid Therapy; Glucaric Acid; Hematinics; Humans; Jehovah's Witnesses; Male; Oxygen Inhalation Therapy; Recombinant Proteins; Severity of Illness Index; Vitamin B 12; Vitamin B Complex | 2013 |
The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis.
Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fibrinogen; Glucaric Acid; Hemoglobins; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Renal Dialysis; ROC Curve; Sucrose | 2013 |
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness.
Topics: Aged; Anemia; Aortic Aneurysm, Abdominal; Blood Loss, Surgical; Critical Illness; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron Compounds; Jehovah's Witnesses; Male; Recombinant Proteins; Salvage Therapy | 2015 |
[Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
Topics: Adult; Anemia; Biomarkers; Disease Progression; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Glucuronidase; Hematinics; Hemoglobins; Humans; Iron; Klotho Proteins; Male; Middle Aged; Outcome Assessment, Health Care; Renal Dialysis; Renal Insufficiency, Chronic; Severity of Illness Index | 2016 |
Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblasts; Glucaric Acid; Hep G2 Cells; Humans; Iron; Kidney; Mice; Oxidative Stress; Up-Regulation; Ureteral Obstruction | 2017 |